CellDetect® Bladder

 
Bladder Cancer is the fourth most common cancer among men in Europe and the U.S. With up to 80% recurrence, bladder cancer requires lifelong surveillance, making it one of the most expensive cancers in terms of lifetime cost per patient. In this context, there is a real need for non-invasive, accurate, simple and cost effective diagnostic solutions.

CellDetect Bladder is an innovative urinary marker for the early detection of bladder cancer in urine specimens. Combining color and morphology, CellDetect is particularly useful for the detection of low grade tumors. It was also shown to predate bladder cancer relapse, making it an effective early indicator of recurrence.

CellDetect Bladder is also approved for use in EuropeIsrael and other territories.

Leaflet CellDetect® Bladder

Atlas CellDetect® Bladder

References:

Idelevich et al. Utilization of CellDetect in bladder cancer diagnosis and recurrance: a prospective comparison with urine cytology and Urovysion FISH. Poster presnted in FOIU annual meeting in Tel-Aviv, July 2018

Qaiser et al. CellDetect
® testing for the diagnosis and surveillance of bladder cancer in routine clinical settings, health service laboratories; The Royal Free Hospital experience. Poster presented at ECC annual meetin in Madrid, May 2018

Wilchfort et at. CellDetect® improves performance of bladder cancer diagnosis compared to standard cytology and U-FISH. Poster presnted at ECC annual meeting in Madrid, May 2018

VandenBussche et al. CellDetect® Improves the sensitivity for detecting bladder cancer in voided urine specimens. Poster presented at USCAP annual meeting in Vancouver, March 2018  

Idelevich et al. CellDetect®: an excellent staining test for accurate diagnosis of urine cytology. Poster presented at USCAP annual meeting in Vancouver, March 2018

Bejar et al. Improved detection of urothelial carcinoma in cytology smears by using CellDetect® innovative staining. Poster presented at USCAP annual meeting in Vancouver, March 2018

Shtabsky et al. CellDetect® histochemical stain for the monitoring of urothelial carcinoma in clinical setting. Poster presented at ASC annual meeting in Pheonix, AZ, November 2017

Bejar et al. Innovative urinary marker for routine use in the identification of bladder cancer. Poster presented at ASC annual meeting in Pheonix, AZ, November 2017

Bejar et al. Routine use of CellDetect® for the identification of urothelial carcinoma in voided urine. Presnted at the ECP annual meeting in Amsterdam September 2017

Shtabsky et al. Feasebility of CellDetect® platform added on cytology for bladder cancer monitoring in a clinical setting. Presented at ECP annual meeting in Amsterdam September 2017

Nativ et al. Performance of a novel urine-based biomarker for the monitoring of bladder cancer recurrence. Abstract 17-1339 presented at AUA in Boston, May 2017

Glickman et al. Combining color and morphology to detect low-grade urothelial carcinoma in urine specimens. Archives in Cancer Research 2016; 4:121

Davis et al. A novel urine-based assay for bladder cancer diagnosis: a multi-institutional validation study. European Urology Focus 2016

Bejar et al. A reproducibility study to evaluate the performance of a novel urine-based biomarker (CellDetect) for the identification of urothelial cancer cells in voided urine. Abstract presented at ECC in Liverpool, Sept 2016

Lindner et al. Color and morphology combination for detection of low-grade urothelial cell cancer: a multi-center validation study. Abstract presented at EAU in Munich, March 2016

Shtabsky et al. Combining color and morphology improves identification of low grade urothelial cancer cells. Abstract presented at ECP in Belgrade, Sept 2015

Davis et al. Automated detection of cancerous cells using CellDetect technology. Abstract presented at ECP in Belgrade, Sept 2015

Glickman. Color power for cancer management. The Pathologist 2015, issue 0615, article 502


Yossepovitch et al. A novel urine cytology stain for the detection and monitoring of urothelial carcinoma. Abstract presented at AUA in New Orleans, May 2015

Davis et al. A novel urine cytology stain for the detection and monitoring of bladder cancer. The Journal of Urology 2014; 192:1628-1632





 
© Micromedic Technologies Ltd. site mapcontact
 
Site by Site2goal | Design Studio Michal Lehavi